Drug Discovery Featured Articles & Applications

31. AI Is A Tool — Not A Replacement — For Human Innovation In Drug Discovery 9/4/2024

    This attorney provides practical advice. Can artificial intelligence (AI) make drug discovery easier? Yes! Will we lose the human component essential to the innovation culture? No.

32. Does Targeting Macrophages Hold The Key For Treating Cancer? 8/30/2024

    What is the role of macrophages, macrophage checkpoint inhibitors, and targeting immune receptor CD24 in treating cancer? What’s needed for clinical success in this space? 

33. Great siRNA Science Or Savvy Business Acumen? You Need Both 8/28/2024

    Silence Therapeutics has two wholly owned siRNA therapies now in clinical trials and one partnered program with AstraZeneca. Silence's CEO discusses the need for good science, making smart business decisions, and cultivating partnerships.

34. The Search For A Chemotherapy-Free Treatment For Patients With Blood Cancer 8/19/2024

    Blood cancer treatment options have long been limited and often come with serious short- and long-term side effects. AbbVie then is embarking on a new, chemotherapy-free way to treat this most common leukemia among adults.

35. Bridge RNAs: Principles, Applications, And Challenges 8/1/2024

    Bridge RNAs are structured noncoding RNAs that facilitate programmable recombination between target and donor DNA, enabling precise genomic rearrangements. A significant advantage is their modularity.

36. Is Your Lab Ready For A LIMS Implementation? 7/25/2024

    Deploying a laboratory information management system (LIMS) can boost your quality control lab's productivity, but how are you going about it? This article shares key steps and considerations for setting up your physical lab, controlling inventory, and more.

37. Correct But Misleading: AI Hallucinations In Complex Decision-Making 7/11/2024

    Managing risks associated with AI hallucinations requires "explainability," a process that identifies patterns or behaviors in AI models that are inconsistent with training data or logical expectations. Regulators are mandating transparency in AI models used for drug testing and development.

38. Harnessing The Power Of the Innate Immune System In Cancer Research 7/9/2024

    The body’s innate immune system — natural killer cells in particular — has emerged as a promising avenue for cancer researchers.

39. ChatGPT-4: Practical Applications For The Biopharma Laboratory 7/3/2024

    AI has made its way into the biopharma laboratory, and ChatGPT-4 is the most popular. Do you know the capabilities that this tech can deliver?

40. Discovering "Molecular Hallmarks" And "Master Regulators" In Epilepsy 7/2/2024

    As we look into the future, understanding the molecular hallmarks of epilepsies will be vital, and insights into the genetics and disease pathways will play a key role. The expert also discusses some of UCB's work in this area.